Jenburkt Pharmaceuticals Ltd
company logo

Jenburkt Pharmaceuticals Ltd

Pharmaceuticals
Small Cap

-

- (0%)

Jenburkt Pharmaceuticals Ltd Performance

-

-

-

-


-

-

-

-

-

Jenburkt Pharmaceuticals Ltd Fundamentals

382.08Cr

14.73

2.64

0.01

58.76

1.77%

328.42

i buttonClick here to know more about Fundamentals

Jenburkt Pharmaceuticals Ltd Financials

Jenburkt Pharmaceuticals Ltd Financialsright-arrow

Jenburkt Pharmaceuticals Ltd Shareholding Pattern

Jenburkt Pharmaceuticals Ltd Delivery and Volume

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Present

Ashish U Bhuta

1985

-

NameDesignation
Ashish R ShahCompany Sec. & Compli. Officer
Ashish U BhutaChairman & Managing Director
Dilip H BhutaWhole Time Director & CFO
Hina Ravindra MehtaNon-Exec. & Independent Dir.
Sumit Ajaybhai ThakkarIndependent Director
KRISHNAN SUBHARAMANIndependent Director
PANKAJ .Independent Director
News and Events...

Similar Stocks

What's Trending

Jenburkt Pharmaceuticals Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Jenburkt Pharmaceuticals Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Jenburkt Pharmaceuticals Ltd's share price is ₹865.75 as of 2024-07-23.
Jenburkt Pharmaceuticals Ltd's P/E ratio is 14.73 times as of 2024-07-23.
Jenburkt Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 2.64, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Jenburkt Pharmaceuticals Ltd's market capitalization is ₹382.08 Cr as on 2024-07-23.
The current financial records of Jenburkt Pharmaceuticals Ltd show a 19.44% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Jenburkt Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹112.11, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Jenburkt Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Jenburkt Pharmaceuticals Ltd's 52-week high and low as of 2024-07-23 are ₹878 and ₹853.5, respectively.